Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Haut

Showing results (11-20 of 36) with videos related to

Pageof 4
Sort By:
Cancer|December 1, 1977
Combination therapy for multiple myelomaR Alexanian, S Salmon, J Bonnet, et al.
Cancer|April 15, 1981
Chemoimmunotherapy for multiple myelomaR Alexanian, S Salmon, J Gutterman, et al.
Cancer Treatment Reports|July 1, 1978
Piperazinedione in patients with advanced malignant melanoma: a Southwest Oncology Group studyM Al-Sarraf, T Thigpen, C W Groppe, et al.
Cancer Treatment Reports|July 1, 1981
Treatment of recurrent lymphomas with vincristine, BCNU, doxorubicin, and prednisone (VBAP): a Southwest Oncology Group StudyJ K Weick, S E Jones, A Haut, et al.
Archives of Physical Medicine and Rehabilitation|May 11, 2001
A multifactorial study of age bias among rehabilitation professionalsB Rybarczyk, A Haut, R F Lacey, et al.
Cancer Treatment Reports|March 1, 1984
Addition of cisplatin and bleomycin to vincristine-carmustine-doxorubicin-prednisone (VBAP) combination in the treatment of relapsing or resistant multiple myeloma: a Southwest Oncology Group studyJ D Bonnet, R Alexanian, S E Salmon, et al.
Cancer Treatment Reports|June 1, 1982
Vincristine, BCNU, doxorubicin, and prednisone (VBAP) combination in the treatment of relapsing or resistant multiple myeloma: a Southwest Oncology Group studyJ Bonnet, R Alexanian, S Salmon, et al.
Cancer Chemotherapy Reports|November 1, 1975
Adriamycin (NSC-123127) plus 5-fluorouracil (NSC-19893): a phase I studyB L Tranum, R L Stephens, D E Lehane, et al.
Cancer|July 1, 1973
CCNU (1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea, NSC-79037) in the treatment of cancer. Phase II studyB Hoogstraten, J A Gottlieb, E Caoili, et al.
Cancer Treatment Reports|August 1, 1979
Phase II evaluation of hexamethylmelamine in advanced breast cancer: a Southwest Oncology Group studyC J Fabian, S Rasmussen, R Stephens, et al.
Pageof 4

Showing results (11-20 of 36) with videos related to

Sort By:
Pageof 4
Cancer|December 1, 1977
Combination therapy for multiple myelomaR Alexanian, S Salmon, J Bonnet, et al.
Cancer|April 15, 1981
Chemoimmunotherapy for multiple myelomaR Alexanian, S Salmon, J Gutterman, et al.
Cancer Treatment Reports|July 1, 1978
Piperazinedione in patients with advanced malignant melanoma: a Southwest Oncology Group studyM Al-Sarraf, T Thigpen, C W Groppe, et al.
Cancer Treatment Reports|July 1, 1981
Treatment of recurrent lymphomas with vincristine, BCNU, doxorubicin, and prednisone (VBAP): a Southwest Oncology Group StudyJ K Weick, S E Jones, A Haut, et al.
Archives of Physical Medicine and Rehabilitation|May 11, 2001
A multifactorial study of age bias among rehabilitation professionalsB Rybarczyk, A Haut, R F Lacey, et al.
Cancer Treatment Reports|March 1, 1984
Addition of cisplatin and bleomycin to vincristine-carmustine-doxorubicin-prednisone (VBAP) combination in the treatment of relapsing or resistant multiple myeloma: a Southwest Oncology Group studyJ D Bonnet, R Alexanian, S E Salmon, et al.
Cancer Treatment Reports|June 1, 1982
Vincristine, BCNU, doxorubicin, and prednisone (VBAP) combination in the treatment of relapsing or resistant multiple myeloma: a Southwest Oncology Group studyJ Bonnet, R Alexanian, S Salmon, et al.
Cancer Chemotherapy Reports|November 1, 1975
Adriamycin (NSC-123127) plus 5-fluorouracil (NSC-19893): a phase I studyB L Tranum, R L Stephens, D E Lehane, et al.
Cancer|July 1, 1973
CCNU (1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea, NSC-79037) in the treatment of cancer. Phase II studyB Hoogstraten, J A Gottlieb, E Caoili, et al.
Cancer Treatment Reports|August 1, 1979
Phase II evaluation of hexamethylmelamine in advanced breast cancer: a Southwest Oncology Group studyC J Fabian, S Rasmussen, R Stephens, et al.
Pageof 4